Pacific Biosciences Of California | PACB - Ebitda


Pacific Biosciences Of California reported $-35.4M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Danaher USD 1.84B 81M Jun/2026
General Electric Aerospace USD 3.06B 219M Jun/2026
Illumina USD 330M 80M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quidel USD 108.7M 44.6M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Roche Holding CHF 13.43B 744M Jun/2026
Standard Biotools USD -8.01M 7.8M Mar/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Waters USD 380.97M 85.83M Dec/2025